Round Rock Advisors’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$578K Buy
31,498
+41
+0.1% +$677 0.08% 178
2026
Q2
$459K Hold
31,457
– – 0.06% 225
2026
Q1
$233K Buy
+31,457
New +$331K 0.04% 295

Other funds holding NEO

Round Rock Advisors's NEO Position: Q3 2026 in Review

Round Rock Advisors increased its NeoGenomics (NEO) stake by 0.13% in Q3 2026, buying an estimated $677 and bringing the position to 31,498 shares worth $578K. The position accounts for 0.08% of the portfolio, ranked #178.

Round Rock Advisors first reported a position in NEO in Q1 2026 and has held it in 3 quarters since. 297 funds tracked by Wall St. Rank hold NEO as of Q3 2026.

  • Round Rock Advisors held 31,498 shares of NeoGenomics worth $578K as of Q3 2026.
  • Round Rock Advisors bought 41 NeoGenomics shares in Q3 2026, an estimated $677.
  • NeoGenomics made up 0.08% of Round Rock Advisors's portfolio in Q3 2026, its #178 holding.
  • Round Rock Advisors first reported a position in NeoGenomics in Q1 2026 and has held it in 3 quarters since.
  • 297 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2026.

Based on Round Rock Advisors's 13F filing for Q3 2026, filed 12 Nov 2026.